Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 6;77(Suppl_1):i35-i42.
doi: 10.1093/jac/dkac215.

Country data on AMR in Brazil in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome

Didem Torumkuney  1 , Puja Nijhara  2 , Cristiana Ossaille Beltrame  3 , Elisama Queiroz Baisch  3 , Ricardo Macarini Ferreira  3
Affiliations

Country data on AMR in Brazil in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome

Didem Torumkuney et al. J Antimicrob Chemother. .

Abstract

Background: Antimicrobial resistance (AMR) is one of the biggest threats to global public health. Selection of resistant bacteria is driven by inappropriate use of antibiotics, amongst other factors. COVID-19 may have exacerbated AMR due to unnecessary antibiotic prescribing. Country-level knowledge is needed to understand options for action.

Objectives: To review the situation with respect to AMR in Brazil and initiatives addressing it. Identifying areas where more information is required will provide a call to action to minimize any further rises in AMR within Brazil and to improve patient outcomes.

Methods: National initiatives to address AMR, antibiotic use and prescribing in Brazil, and availability of susceptibility data, particularly for the key community-acquired respiratory tract infections (CA-RTI) pathogens Streptococcus pneumoniae and Haemophilus influenzae, were identified. National and international antibiotic prescribing guidelines for CA-RTIs (community-acquired pneumonia, acute otitis media and acute bacterial rhinosinusitis) commonly used locally were also reviewed, along with local antibiotic availability.

Conclusions: In Brazil there have been some initiatives addressing AMR such as the National Action Plan for AMR, established in 2018. Antibiotic consumption in Brazil is high but a ban on over-the-counter sales of antibiotics has led to a decrease in consumption. Local antibiotic susceptibility testing needs to be increased and the Survey of Antibiotic Resistance (SOAR) study in Brazil will provide useful data for pathogens causing CA-RTIs. A more standardized inclusive approach in developing local guidelines, using up-to-date surveillance data of isolates from community-acquired infections in Brazil, could make guideline use more locally relevant for clinicians. This would pave the way for a higher level of appropriate antibiotic prescribing and improved adherence. This would, in turn, potentially limit AMR development and improve clinical outcomes for patients.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Percentage susceptibility rates based on CLSI breakpoints for antibiotics against S. pneumoniae isolates from the ATLAS surveillance programme in Brazil 2015–16. Data access date 21 November 2021.
Figure 2.
Figure 2.
Percentage susceptibility rates based on CLSI breakpoints for antibiotics against H. influenzae isolates from the ATLAS surveillance programme in Brazil 2016–19. Data access date 21 November 2021.
Figure 3.
Figure 3.
Percentage susceptibility rates based on CLSI breakpoints for antibiotics against S. pneumoniae isolates from the SENTRY surveillance programme in Brazil 2014–19. Data access date 21 November 2021.
Figure 4.
Figure 4.
Percentage susceptibility rates based on CLSI breakpoints for antibiotics against H. influenzae isolates from the SENTRY surveillance programme in Brazil 2014–18. Data access date 21 November 2021.
See this image and copyright information in PMC

References

    1. WHO . Antibiotic resistance—fact sheet. 2020. https://www.who.int/news-room/fact-sheets/detail/antibiotic-resistance.
    1. Cantón R, Akova M, Langfeld Ket al. . Relevance of the Consensus Principles for Appropriate Antibiotic Prescribing in 2022. J Antimicrobial Chemother 2022; 77Suppl 1: dkac211. - PMC - PubMed
    1. WHO . Antimicrobial resistance—fact sheet. 2021. https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance.
    1. Correa R, José BPS, Malta DCet al. . Burden of disease by lower respiratory tract infections in Brazil, 1990 to 2015: estimates of the Global Burden of Disease 2015 study. Rev Bras Epidemiol 2017; 20: 171–81. doi: 10.1590/1980-5497201700050014 - DOI - PubMed
    1. Klein EY, Van Boeckeld TP, Martinez EMet al. . Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc Natl Acad Sci U S A 2018; 115: E3463–70. doi: 10.1073/pnas.1717295115 - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

Grants and funding